Literature DB >> 4823813

Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.

E R Block, J E Bennett, L G Livoti, W J Klein, R R MacGregor, L Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4823813     DOI: 10.7326/0003-4819-80-5-613

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  29 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

2.  Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.

Authors:  T G Christopher; A D Blair; A W Forrey; R E Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

3.  5-fluorocytosine and amphotericin B in bronchial secretions.

Authors:  J E Pennington; E R Block; H Y Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

Review 4.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

5.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

6.  Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.

Authors:  R Bhamra; A Sa'ad; L E Bolcsak; A S Janoff; C E Swenson
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Risk factors of ventricular fibrillation during rapid amphotericin B infusion.

Authors:  P C Craven; D H Gremillion
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

8.  Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.

Authors:  G Robbie; W L Chiou
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

Review 9.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

10.  Amphotericin B pharmacokinetics in humans.

Authors:  A J Atkinson; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.